Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2019-08-02
2021-05-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Remote transmission of laboratory results, replacing fax communication might facilitate the coordination of care that results from these laboratory results and provide a better respect of the Plan Custom Care Transfusion (PPST).
The investigators offer organization of transfusion supportive care for patients with conditions requiring biological monitoring using the techniques of information and communication telemedicine.
Primary objective
\- Assess the feasibility of setting up an upload procedure biological results in the treatment of transfusion supportive care.
Secondary objectives
* Assess the evolution of the quality of life of patients during the treatment
* Assess changes in patient satisfaction over the support
* Assess the evolution of the satisfaction of the medical team at home and at Toulouse University Hospital
* Describe the programming time (hospitalization, consultations)
* Estimate the loss of biological results
* Assessment of the descriptive use of hospitalization, consultation and biological examinations in both groups. This remedy shall be valued in Euros thanks to GHS rates for hospitalizations, general nomenclature for Professional acts (NGAP) and biology nomenclature (NABM) for biological tests.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Home Blood Transfusions
NCT07121140
Cord Blood Transplantation in Patients With Advanced Lymphoid Malignancies
NCT01966510
Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation
NCT00737516
Lipopolysaccharide Metabolism and Identification of Potential Biomarkers Predictive of Graft-versus-host Disease After Allogeneic Stem Cell Transplantation
NCT03918343
Home Transfusion for HEME
NCT05509439
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The establishment of an electronic transmission enables the regulation of all hospitalizations throughout the patient care pathway and reinforces the link city / hospital through the receipt of laboratory results and issuing information to the partners of the care network patient. The PPST will be transmitted by secure messaging.
The primary endpoint is the proportion of transfusion episodes where PPST is respected. The proportion of patients whose care meets the PPST for 3 successive transfusion episodes will also be estimated.
The secondary endpoints are:
* The Patient satisfaction questionnaires (relative to the consideration of the results, the management procedures) in 3 successive transfusions.
* The Quality of life of the patient assessed by questionnaire (EORTC-QLQC30 and EQ5D) at baseline and after 3 successive transfusion episodes.
* The Satisfaction surveys of the medical team at home and the service effector transfusion at baseline and after 3 successive transfusion episodes.
* The Response time for a hospitalization or consultation program on the study period.
* The Number of lost biological results.
* Evaluation of the descriptive use of hospitalization, consultation, biology.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
telemedicine transmission
telemedicine transmission of biological results in the treatment of transfusion supportive care
telemedicine transmission of biological results
telemedicine transmission of biological informations
without telemedicine transmission
no telemedicine transmission of biological results in treatment in the treatment of transfusion supportive care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
telemedicine transmission of biological results
telemedicine transmission of biological informations
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient agreeing to participate in the project
Exclusion Criteria
* Absence of social coverage .
* Patient under guardianship or trusteeship safeguard justice
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Toulouse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Odile Beyne Rauzy, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Toulouse
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IUCT-O
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12 559 15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.